Search

Promising microRNA study

Promising microRNA study

November 28, 2016

Postdoctoral researcher Cristina Espinosa runs an experiment, November 16, 2016. The early evidence found in research at OHSU by Espinosa, Dr. Sudarshan Anand and his team is promising, suggesting there may be a panel of microRNA that can be used as a biomarker for radiation therapy for many types of cancer in the future.
(OHSU/Kristyna Wentz-Graff)

Donald Sullivan

Donald Sullivan

November 17, 2016

Donald Sullivan, M.D., assistant professor of medicine (hematology/medical oncology) in the OHSU School of Medicine, affiliate researcher at the OHSU Knight Cancer Institute and affiliate investigator with the Portland VA, lead the research.
(OHSU)

Nurse practitioners fill gap by providing timely help in recording end-of-life treatment wishes

October 21, 2016
​Not all states allow nurse practitioners to make a patient’s treatment wishes part of their medical record, yet a six-year study concludes that they can improve seriously ill patients’ access to advance-care planning. Nurse practitioners often serve as the primary care provider or a member of the team caring for patients in the last months of their lives when they are most likely to seek end-of-life treatment counseling.
Fiscal Year 2016 achievements in technology transfer, business development

Fiscal Year 2016 achievements in technology transfer, business development

October 13, 2016
For 11 years, TTBD has hosted an award ceremony to celebrate university accomplishments and recognize OHSU employees who’ve made significant contributions to innovation, entrepreneurship, industry partnership, patenting, and technology commercialization. Following are highlights from last night’s 2016 TTBD Awards Ceremony.
Doernbecher researchers awarded more than $9 million to fight Fanconi anemia

Doernbecher researchers awarded more than $9 million to fight Fanconi anemia

October 10, 2016
Thanks to a $9.9 million grant from the National Heart, Lung, and Blood Institute, a team led by Markus Grompe, M.D., director of the Oregon Stem Cell Center at OHSU and the Papé Family Pediatric Research Institute at OHSU Doernbecher Children’s Hospital, will work to understand human response to novel drug treatments that have shown promise in FA-positive animal models.
See More Stories